is semaglutide compound being discontinued Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s Compounded Semaglutide - Elite Health
Description
doi:10.1002/biof.3 99
Compounded drugs are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality
Additionally, more than 170 peptides are currently in active clinical development, with 38 in phase III clinical trials
Extended Data Figure 4 Effects of binding pocket mutations on potency of NAMs
Physicians should educate patients on the symptoms of kidney issues, like swelling, confusion, or a decrease in urine
